India, April 30 -- Lord's Mark Industries Ltd. today announced that it has received approval from the Central Licensing Authority (Licence No. MFG/IVD/2023/000058) for its LordsMed HIV 1&2 Self Test. With this, the company becomes the second in India among only three approved players nationally, and one of nine companies globally to achieve this milestone. The approval enables the manufacture and export of a Class D in-vitro diagnostic self-test, designed for private use and compliant with India's Medical Devices Rules, 2017.

This approval is specifically for export markets, with the product currently not intended for domestic commercial distribution in India.

With exports set to commence from June 2026, Lord's Mark will enter internati...